Conformationally restricted analogs of 1α,25-dihydroxyvitamin D3 and its 20-epimer: Compounds for study of the three-dimensional structure of vitamin D responsible for binding to the receptor

Journal of Medicinal Chemistry

Volumn 39, Issue 14, 1996, Pages 2727-2737

  Yamamoto, Keiko ^a   Sun, Wei Yan ^a   Ohta, Masateru ^b   Hamada, Kazuhiro ^a   DeLuca, Hector F ^c   Yamada, Sachiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCITRIOL RECEPTOR; VITAMIN BINDING PROTEIN;

ARTICLE; BINDING AFFINITY; DIASTEREOISOMER; DRUG CONFORMATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; RECEPTOR BINDING; STEREOCHEMISTRY; THREE DIMENSIONAL IMAGING;

ANIMALS; BINDING SITES; CALCITRIOL; CATTLE; DRUG DESIGN; MODELS, MOLECULAR; PROTEIN CONFORMATION; RATS; RECEPTORS, CALCITRIOL; SWINE;

EID: 8944263299     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9600048     Document Type: Article

References (39)

1. DeLuca, H. F.; Darwish, H. M.; Ross, T. K.; Moss, V. E. Mechanism of Action of 1,25-Dihydroxyvitamin D on Target Gene Expression. J. Nutr. Sci. Vitaminol. 1992, 19-26.
2. 3 Receptors: Gene Regulation and Genetic Circuitry. FASEB J. 1988, 2, 3043-3053.
3. 3 Receptors: Gene Regulation and Genetic Circuitry. FASEB J. 1988, 2, 3043-3053.
4. 3 Receptors: Gene Regulation and Genetic Circuitry. FASEB J. 1988, 2, 3043-3053.
5. 3 Receptors: Gene Regulation and Genetic Circuitry. FASEB J. 1988, 2, 3043-3053.
6. Evans, R. M. The Steroid and Thyroid Hormone Receptor Superfamily. Science 1988, 240, 889-895. Beato, M. Gene Regulation by Steroid Hormones. Cell 1989, 56, 335-344.
7. Evans, R. M. The Steroid and Thyroid Hormone Receptor Superfamily. Science 1988, 240, 889-895. Beato, M. Gene Regulation by Steroid Hormones. Cell 1989, 56, 335-344.
8. 3, Is a Potent Modulator of In Vivo Immunoregulating Activity without Inducing Hypercalcemia in Mice. Endocrinology 1989, 124, 2645-2647.
9. 3, Is a Potent Modulator of In Vivo Immunoregulating Activity without Inducing Hypercalcemia in Mice. Endocrinology 1989, 124, 2645-2647.
10. (b) Binderup, L.; Bramm, E. Effects of a Novel Vitamin D Analogue MC903 on Cell Proliferation and Differentiation In Vitro and on Calcium Metabolism In Vivo. Biochem. Pharmacol. 1988, 37,889-895.
11. 3 Analogues: A Novel Class of Potent Regulators of Cell Growth and Immune Responses. Biochem. Pharmacol. 1991, 42, 1569-1575.
12. (d) Zhou, J. Y.; Norman, A. W.; Lübbert, M.; Collins, E. D.; Uskokovic, M. R.; Koeffler, H. P. Novel Vitamin D Analogs That Modulate Leukemic Cell Growth and Differentiation with Little Effect on Either Intestinal Calcium Absorption or Bone Calcium Mobilization. Blood 1989, 74, 82-93.
13. 3 Compounds: Separation of Calcium and Cell Differentiation Activities. Biochemistry 1990, 29, 190-196.
14. 3 24-Homologs. J. Biol. Chem. 1991, 266, 1910-1913.
15. (g) Bouillon, R.; Okamura, W. H.; Norman, A. W. Structure-Function Relationships in the Vitamin D Endocrine System. Endocr. Rev. 1995, 16, 200-257.
16. Allan, G. F.; Leng, X.; Tsai, S. Y.; Weigel, N. L.; Edwards, D. P.; Tsai, M.-J.; O'Malley, B. W. Hormone and Antihormone Induce Distinct Conformational Changes Which Are Central to Steroid Receptor Activation. J. Biol. Chem. 1992, 267, 19513-19520.
17. Beekman, J. M.; Allan, G. F.; Tsai, S. Y.; Tsai, M.-J.; O'Malley, B. W. Transcriptional Activation by the Estrogen Receptor Requires a Conformational Change in the Ligand Binding Domain. Mol. Endocrinol. 1993, 7, 1266-1274.
18. Kuil, C. W.; Mulder, E. Mechanism of Antiandrogen Action: Conformational Changes of the Receptor. Mol. Cell. Endocrinol. 1994, 102, R1-R5.
19. 3 Are Associated with Enhanced Activation of the Vitamin D Receptor. J. Biol. Chem. 1995, 270, 10551-10558.
20. 3 Analogs with Restricted Side Chain Conformation. J. Org. Chem. 1993, 58, 2530-2537.
21. 3 Responsible for Binding to the Receptor. BioMed. Chem. Lett. 1995, 5, 979-984.
22. 3. J. Org. Chem. 1995, 60, 1828-1833.
23. 3 Monohydrate: A Stereochemical Analysis of Vitamin D Molecules. J. Chem. Soc., Perkin Trans. 2 1977, 393-401.
24. BIOSYM Technologies, Inc., 9685 Scranton Rd., San Diego, CA 92121-3752.
25. TRIPOS Inc., 1699 South Hanley, Suite 303, St. Louis, MO 63144-2913.
26. MMX (an enhanced version of MM2) was calculated by using software PCMODEL (Serena Software, Bloomington).
27. 3OCO, R′ = H, and 15, R = R′ = H) and with butyl group in the place of the methyl at C(22)] gave single crystals. However all these crystals contained four molecules in their unit cells. Solution of the crystal structure of compounds with these high formula weights (about 2000) is nearly impossible.
28. Yamamoto, K.; Yamada, S.; Yamaguchi, K. Highly Diastereo-selective Conjugate Addition of Organocuprate to Acyclic E- and Z-Enones: Reversal Stereoselectivity under Kinetic and Thermodynamic Conditions. Tetrahedron Lett. 1992, 33, 7521-7524.
29. 7a and then that of 14′ to be R. Since the reactivity and the face selectivity under kinetic as well as thermodynamic conditions are parallel in the 20R- and 20S-enones, the configurations at C(22) of 13 and 14 were assigned with high probability to be R and S, respectively (those of 15 and 16 to be S and R, respectively). Equation presented
30. 3: Interaction with Distinct Receptor Domains. Biochemistry 1986, 25, 4523-4534.
31. 3: Interaction with Distinct Receptor Domains. Biochemistry 1986, 25, 4523-4534.
32. 2 and its 24-Epimer. Biochim. Biophys. Acta 1994, 1213, 302-308.
33. 3 Is Due to Reduced Catabolism and Altered Protein Binding. Biochem. Pharmacol. 1994, 47, 987-993.
34. Okamura's group has reported a dot map for models of 1 and its analogs to study the structure-activity relationships; see: Okamura, W. H.; Palenzuela, J. A.; Plumet, J.; Midland, M. M. Vitamin D: Structure-Function Analyses and the Design of Analogs. J. Cell. Biochem. 1992, 49, 10-18. Midland, M. M.; Plumet, J.; Okamura, W. H. Effect of C20 Stereochemistry on the Conformational Profile of the Side Chains of Vitamin D Analogs. BioMed. Chem. Lett. 1993, 3, 1799-1804.
35. Okamura's group has reported a dot map for models of 1 and its analogs to study the structure-activity relationships; see: Okamura, W. H.; Palenzuela, J. A.; Plumet, J.; Midland, M. M. Vitamin D: Structure-Function Analyses and the Design of Analogs. J. Cell. Biochem. 1992, 49, 10-18. Midland, M. M.; Plumet, J.; Okamura, W. H. Effect of C20 Stereochemistry on the Conformational Profile of the Side Chains of Vitamin D Analogs. BioMed. Chem. Lett. 1993, 3, 1799-1804.
36. (a) Dawson, M. I.; Jong, L.; Hobbs, P. D.; Cameron, J. F.; Chao, W.; Pfahl, M.; Lee, M.; Shroot, B.; Pfahl, M. Conformational Effects on Retinoid Receptor Selectivity. 2. Effects of Retinoid Bridging Group on Retinoid X Receptor Activity and Selectivity. J. Med. Chem. 1995, 38, 3368-3383.
37. (b) Boehm, M. F.; Zhang, L.; Badea, B. A.; White, S. K.; Mais, D. E.; Berger, E.; Suto, C. M.; Goldman, M. E.; Heyman, R. A. Synthesis and Structure-Activity Relationships of Novel Retinoid X Receptor-Selective Retinoids. J. Med. Chem. 1994, 37, 2930-2941.
38. (c) Shimamoto, K.; Ishida, M.; Shinozaki, H.; Ohfune, Y. Synthesis of Four Diastereomeric L-2-(Carboxycyclopropyl)glycines. Conformationally Constrained L-Glutamate Analogues. J. Org. Chem. 1991, 56, 4167-4176.
39. 7a